• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于死亡率动态(癌症与非癌症)衡量的现患癌症病例的健康状况:在五个主要癌症部位的应用。

Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites.

机构信息

Isere Cancer Registry, University Hospital of Grenoble, Grenoble, France.

French Network of Cancer Registries (FRANCIM), Toulouse, France.

出版信息

Cancer. 2022 Oct;128(20):3663-3673. doi: 10.1002/cncr.34413. Epub 2022 Aug 16.

DOI:10.1002/cncr.34413
PMID:35972380
Abstract

BACKGROUND

Cancer prevalence is heterogeneous because it includes individuals who are undergoing initial treatment and those who are in remission, experiencing relapse, or cured. The proposed statistical approach describes the health status of this group by estimating the probabilities of death among prevalent cases. The application concerns colorectal, lung, breast, and prostate cancers and melanoma in France in 2017.

METHODS

Excess mortality was used to estimate the probabilities of death from cancer and other causes.

RESULTS

For the studied cancers, most deaths from cancer occurred during the first 5 years after diagnosis. The probability of death from cancer decreased with increasing time since diagnosis except for breast cancer, for which it remained relatively stable. The time beyond which the probability of death from cancer became lower than that from other causes depended on age and cancer site: for colorectal cancer, it was 6 years after diagnosis for women (7 years for men) aged 75-84 and 20 years for women (18 years for men) aged 45-54 years, whereas cancer was the major cause of death for women younger than 75 years whatever the time since diagnosis for breast and for all patients younger than 75 years for lung cancer. In contrast, deaths from other causes were more frequent in all the patients older than 75 years. Apart from breast cancer in women younger than 55 years and lung cancer in women older than 55 years and men older than 65 years, the probability of death from cancer among prevalent cases fell below 1%, with varying times since diagnosis.

CONCLUSIONS

The authors' approach can be used to better describe the burden of cancer by estimating outcomes in prevalent cases.

摘要

背景

癌症的患病率存在差异,因为它包括正在接受初始治疗的患者和处于缓解期、复发或治愈的患者。所提出的统计方法通过估计现患病例的死亡概率来描述这一人群的健康状况。该应用涉及法国 2017 年的结直肠癌、肺癌、乳腺癌和前列腺癌以及黑色素瘤。

方法

使用超额死亡率来估计癌症和其他原因导致的死亡概率。

结果

在所研究的癌症中,大多数癌症死亡发生在诊断后 5 年内。除乳腺癌外,随着诊断后时间的延长,死于癌症的概率降低,而乳腺癌的这一概率相对稳定。死于癌症的概率低于其他原因的概率的时间取决于年龄和癌症部位:对于 75-84 岁的女性(男性为 6 年)和 45-54 岁的女性(男性为 20 年),结直肠癌的诊断后 6 年(男性为 7 年),而乳腺癌则是 75 岁以下女性的主要死亡原因,无论诊断后时间如何,对于所有 75 岁以下的患者,肺癌也是如此。相比之下,所有 75 岁以上的患者死于其他原因的概率更高。除了 55 岁以下女性的乳腺癌和 55 岁以上女性和 65 岁以上男性的肺癌之外,现患病例死于癌症的概率随着诊断后时间的不同而下降到 1%以下。

结论

作者的方法可用于通过估计现患病例的结局来更好地描述癌症负担。

相似文献

1
Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites.基于死亡率动态(癌症与非癌症)衡量的现患癌症病例的健康状况:在五个主要癌症部位的应用。
Cancer. 2022 Oct;128(20):3663-3673. doi: 10.1002/cncr.34413. Epub 2022 Aug 16.
2
Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.基于净生存无偏估计的法国癌症患者癌症和其他原因死亡概率:五种常见癌症的研究。
Cancer Epidemiol. 2013 Dec;37(6):857-63. doi: 10.1016/j.canep.2013.08.006. Epub 2013 Sep 22.
3
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].[国家重点污染场地居民流行病学研究。第六次报告]
Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003.
4
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
5
[Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].[意大利撒丁岛工业、采矿或军事基地所在地区居民健康状况报告]
Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 1):5-95.
6
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.《2014年意大利癌症数据报告:意大利癌症的患病率与治愈率》
Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 1):1-122. doi: 10.19191/EP14.6.S1.113.
7
Long-Term Survival and Causes of Death After Diagnoses of Common Cancers in 3 Cohorts of US Health Professionals.3 项美国健康专业人员队列研究中常见癌症诊断后的长期生存和死亡原因。
JNCI Cancer Spectr. 2022 Mar 2;6(2). doi: 10.1093/jncics/pkac021.
8
Estimates of cancer burden in Campania.坎帕尼亚地区癌症负担的估计。
Tumori. 2013 May-Jun;99(3):374-81. doi: 10.1177/030089161309900313.
9
Estimates of cancer burden in Lazio.拉齐奥地区癌症负担的估计。
Tumori. 2013 May-Jun;99(3):359-65. doi: 10.1177/030089161309900311.
10
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.基于人群的早期乳腺癌患者心血管死亡率研究。
JAMA Cardiol. 2017 Jan 1;2(1):88-93. doi: 10.1001/jamacardio.2016.3841.

引用本文的文献

1
A population-based estimation of breast cancer recurrence in northeast Italy with administrative healthcare databases.利用行政医疗保健数据库对意大利东北部乳腺癌复发情况进行基于人群的估计。
Breast. 2025 May 1;82:104487. doi: 10.1016/j.breast.2025.104487.
2
Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030.将被治愈的癌症患者以及意大利2018年至2030年的完全患病率预测。
ESMO Open. 2024 Jul;9(7):103635. doi: 10.1016/j.esmoop.2024.103635. Epub 2024 Jul 23.
3
Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
女性子宫癌和卵巢癌存活后的治愈指标:基于人群的研究。
Am J Epidemiol. 2024 Sep 3;193(9):1224-1232. doi: 10.1093/aje/kwae044.
4
Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker.免疫组织化学检测 p16 肿瘤标志物在高危型人乳头瘤病毒感染宫颈活检样本中的表达。
Arch Microbiol. 2023 Dec 12;206(1):17. doi: 10.1007/s00203-023-03736-0.
5
Potential for Cure by Stage across the Cancer Spectrum in the United States.美国不同癌症阶段的治愈潜力。
Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):206-214. doi: 10.1158/1055-9965.EPI-23-1018.
6
Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.基于医院的回顾性队列研究:按检出途径分类的甲状腺乳头状癌患者死亡率。
Eur Thyroid J. 2023 Nov 6;12(6). doi: 10.1530/ETJ-23-0127. Print 2023 Dec 1.
7
New Copper Complexes with Antibacterial and Cytotoxic Activity.新型具有抗菌和细胞毒性活性的铜配合物。
Int J Mol Sci. 2023 Sep 7;24(18):13819. doi: 10.3390/ijms241813819.
8
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.癌症治愈的总体患病率及指标:意大利基于人群的癌症登记处的强化方法与验证
Front Oncol. 2023 Jun 6;13:1168325. doi: 10.3389/fonc.2023.1168325. eCollection 2023.
9
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes.估算欧洲癌症总体患病率:替代完整性指数与标准完整性指数的有效性
Front Oncol. 2023 Apr 24;13:1114701. doi: 10.3389/fonc.2023.1114701. eCollection 2023.